Oxygen-induced pulmonary vasodilation is mediated by adenosine triphosphate in newborn lambs

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 1, 1997, Pages 102-109

  Crowley, Mark R ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine; Adenosine triphosphate; Endothelium derived nitric Oxide; Oxygen; Pulmonary hypertension; Purinergic receptors

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 8 PHENYLTHEOPHYLLINE; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; N(G) NITROARGININE; NITROPRUSSIDE SODIUM; OXYGEN; PURINERGIC RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FETUS; HEMODYNAMIC MONITORING; LAMB; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG CIRCULATION; NEWBORN; NEWBORN MONITORING; NONHUMAN; OXYGEN SUPPLY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECEPTOR BLOCKING; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; ANIMALS, NEWBORN; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HEMODYNAMIC PROCESSES; HYPERTENSION, PULMONARY; NITRIC OXIDE; NITROARGININE; OXYGEN; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; PULMONARY ARTERY; RECEPTORS, PURINERGIC; SHEEP; THEOPHYLLINE; THROMBOXANE A2; TRIAZINES; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 0030691996     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199707000-00015     Document Type: Article

References (30)

1. Behrman RE. Persistence of the fetal circulation. J Pediatr 1976; 89:636-44.
2. Kulik TJ, Lock JE. Pulmonary vasodilator therapy in persistent pulmonary hypertension of the newborn. Clin Perinatol 1984;11:693-701.
3. Drummond WH, Gregory GA, Heymann MA, Phibbs RA. The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension. J Pediatr 1981;98:603-11.
4. Drummond WH, Lock JE. Neonatal "pulmonary vasodilator" drugs: current status. Dev Pharmacol Ther 1984;7:1-20.
5. Fox WW, Duara S. Persistent pulmonary hypertension in the neonate: diagnosis and management. J Pediatr 1983;103:505-14.
6. Kinsella JP, Abman SH. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr 1995;126:853-64.
7. Fineman JR, Wong J, Morin FC, Wild LM, Soifer SJ. Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs. J Clin Invest 1994;93:2675-83.
8. Konduri GG, Theodorou AA, Mukhopadhyay A, Deshmukh DR. Adenosine triphosphate and adenosine increase the pulmonary blood flow to postnatal levels in fetal lambs. Pediatr Res 1992;31:451-7.
9. Morin FC, Egan EA. Pulmonary hemodynamics in fetal lambs during development at normal and increased oxygen tension. J Appl Physiol 1992;73:213-8.
10. Morin FC, Egan EA, Ferguson W, Lundgren CEG. Development of pulmonary vascular response to oxygen. Am J Physiol 1988;254:542-6.
11. Shaul PW, Farrar MA, Zellers TM. Oxygen modulates endothelium-derived relaxing factor production in fetal pulmonary arteries. Am J Physiol 1992;262:355-64.
12. Moore PH, Velvis H, Fineman JR, Soifer SJ, Heymann MA. EDRF inhibition attenuates the increase in pulmonary blood flow due to oxygen in fetal lambs. J Appl Physiol 1992;73:2151-7.
13. Konduri GG, Gervasio CT, Theodorou AA. Role of adenosine triphosphate and adenosine in oxygen-induced pulmonary vasodilation in fetal lambs. Pediatr Res 1993;33:533-9.
14. Konduri GG, Woodard LL, Mukhopadhyay A, Deshmukh DR. Adenosine is a pulmonary vasodilator in newborn lambs. Am Rev Respir Dis 1992;146:670-6.
15. 2 during pulmonary hypertension in lambs. J Appl Physiol 1990;69:1836-42.
16. Fineman JR, Wong J, Soifer SJ. Hyperoxia and alkalosis produce pulmonary vasodilation independent of endothelium-derived nitric oxide in newborn lambs. Pediatr Res 1993;33:341-6.
17. 2 in the evaluation and treatment of children with pulmonary hypertension secondary to congenital heart defects. Circulation 1994;90:1287-93.
18. Paidas CN, Dudgeon DL, Haller JA, Clemens MG. Adenosine triphosphate: a potential therapy for hypoxic pulmonary hypertension. J Pediatr Surg 1988;23:1154-60.
19. Furchgott RF. Role of the endothelium in responses of vascular smooth muscle. Circ Res 1983;53:557-73.
20. Ignarro LJ. Biologic actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989;65:1-21.
21. Fiscus RR. Molecular mechanisms of endothelium-mediated vasodilation. Semin Thromb Hemost 1988;14:12-22.
22. Gordon JL. Extracellular ATP: effects sources and fate. Biochemistry 1986;233:309-19.
23. Bodin P, Bailey D, Burnstock G. Increased flow-induced ATP release from isolated vascular endothelial cells not smooth muscle cells. Br J Phannacol 1991;103:1203-5.
24. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986;250:1145-9.
25. Cassin S. Role of prostaglandins, thromboxane and leukotrienes in the control of the pulmonary circulation in the fetus and newborn. Semin Perinatol 1987;11:53-63.
26. Velvis H, Moore P, Heymann MA. Prostaglandin inhibition prevents the fall in pulmonary vascular resistance as a result of rhythmic distension of the lungs in fetal lambs. Pediatr Res 1991;30:62-8.
27. Fineman JR, Crowley MR, Heymann MA, Soifer SJ. In vivo attenuation of endothelium-dependent pulmonary vasodilation by methylene blue. J Appl Physiol 1991;71:735-41.
28. 2-purinoreceptor subtypes in human small pulmonary arteries. Br J Pharmacol 1989;98:1014-20.
29. 2 purinoceptor on the guinea-pig vas deferens. Br J Pharmacol 1985;84:431-4.
30. 2-purinergic receptors in vascular smooth muscle cells: from concept to reality. J Recept Res 1988;8:121-32.